Literature DB >> 32278110

Management of locally advanced oral cancers.

Harsh Dhar1, Richa Vaish2, Anil K D'Cruz3.   

Abstract

Despite easy access to clinical examination majority of oral cancer patients ironically present with locally advanced disease, which is a heterogeneous group that includes all stage III/IV tumours in absence of distant metastasis. The AJCC TNM classification has included all tumours with depth of invasion >1 cm into locally advanced group irrespective of their surface dimensions. Surgery followed by adjuvant therapy provides best results and should be offered to all patients when operable. There have been a slew of recent publications popularising the concept of compartmental excision in variance to traditional resection with adequate margins. The role of chemotherapy has been explored in this group of patients for both organ preservation as well as to aid bioselection of suitable patients with borderline operable tumours for surgery.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Infratemporal fossa; Neoadjuvant therapy; Oral cancer; Oral cancer/ diagnostic imaging; Oral cancer/ surgery; Oral cancer/ therapy; TNM staging

Mesh:

Year:  2020        PMID: 32278110     DOI: 10.1016/j.oraloncology.2020.104662

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  1 in total

1.  Clinical efficacy of highly agglutinative staphylococcin combined with neoadjuvant chemotherapy on patients with intermediate or advanced oral cancer.

Authors:  Nan Guo; Gengbing Lin; Xie Shi
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.